Three versus six months adjuvant oxaliplatin-based chemotherapy for patients with stage III colon cancer: The French participation to the International Duration Evaluation of Adjuvant chemotherapy (IDEA) project.

Affiliation auteurs!!!! Error affiliation !!!!
TitreThree versus six months adjuvant oxaliplatin-based chemotherapy for patients with stage III colon cancer: The French participation to the International Duration Evaluation of Adjuvant chemotherapy (IDEA) project.
Type de publicationJournal Article
Year of Publication2017
AuteursAndre T, Bonnetain F, Mineur L, Bennouna J, Desrame J, Faroux R, Dauba J, Vernerey D, Aissat N, Louvet C, Lepere C, Dupuis OJean Marie, Becouarn Y, Mabro M, Egreteau J, Bouche O, Deplanque G, Ychou M, de Gramont A, Taieb J
JournalJOURNAL OF CLINICAL ONCOLOGY
Volume35
Date PublishedMAY 20
Type of ArticleMeeting Abstract
ISSN0732-183X
DOI10.1200/JCO.2017.35.15_suppl.3500